Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-21 Sale |
2024-02-22 4:36 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
3,966 | $7.45 | $29,547 | 118,361 (Direct) |
View |
| 2024-02-21 Sale |
2024-02-22 4:34 pm |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO |
13,033 | $7.46 | $97,226 | 334,954 (Direct) |
View |
| 2024-02-21 Sale |
2024-02-22 4:32 pm |
Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer |
3,764 | $7.46 | $28,079 | 175,669 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-22 4:30 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
3,967 | $7.5019 | $29,760 | 87,627 (Direct) |
View |
| 2024-01-17 Sale |
2024-01-19 4:34 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
2,543 | $7.15 | $18,182 | 72,327 (Direct) |
View |
| 2024-01-17 Sale |
2024-01-19 4:32 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
1,266 | $7.18 | $9,090 | 53,094 (Direct) |
View |
| 2023-10-03 Sale |
2023-10-05 4:41 pm |
Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer |
13,567 | $6.99 | $94,833 | 149,433 (Direct) |
View |
| 2023-09-15 Sale |
2023-09-18 4:44 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
10,500 | $8.16 | $85,680 | 94,360 (Direct) |
View |
| 2023-07-06 Sale |
2023-07-10 4:42 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
5,500 | $10.8 | $59,400 | 59,860 (Direct) |
View |
| 2023-06-30 Sale |
2023-07-05 4:32 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
5,000 | $11.41 | $57,050 | 110,360 (Direct) |
View |
| 2023-04-03 Sale |
2023-04-05 5:04 pm |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO |
7,437 | $7.83 | $58,232 | 214,618 (Direct) |
View |
| 2023-04-03 Sale |
2023-04-05 5:02 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
1,259 | $7.83 | $9,858 | 71,617 (Direct) |
View |
| 2023-03-20 Sale |
2023-03-22 4:49 pm |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
2,193 | $7.76 | $17,018 | 65,360 (Direct) |
View |
| 2023-03-20 Sale |
2023-03-22 4:48 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
3,654 | $7.76 | $28,355 | 72,876 (Direct) |
View |
| 2023-03-20 Sale |
2023-03-22 4:47 pm |
Voyager Therapeutics Inc. | VYGR | Hesslein Robert W. Senior VP & General Counsel |
4,410 | $7.76 | $34,222 | 102,200 (Direct) |
View |
| 2023-03-15 Sale |
2023-03-17 4:37 pm |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
15,373 | $8.2 | $126,059 | 76,530 (Direct) |
View |
| 2023-02-23 Purchase |
2023-02-24 06:15 am |
Voyager Therapeutics Inc. | VYGR | NEUROCRINE BIOSCIENCES INC 10% Owner |
4,395,588 | $8.88 | $39,032,821 | 8,575,316 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-25 Option Award |
2024-03-26 5:27 pm |
N/A 2034-03-25 |
Voyager Therapeutics Inc. | VYGR | Ferguson Toby Chief Medical Officer |
210,000 | $0 | 210,000 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-16 5:06 pm |
N/A 2034-02-09 |
Voyager Therapeutics Inc. | VYGR | Fahey Sandell Jacquelyn Chief Legal Officer |
93,000 | $0 | 154,000 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-16 5:04 pm |
N/A 2034-02-09 |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
115,500 | $0 | 168,594 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-16 5:03 pm |
N/A 2034-02-09 |
Voyager Therapeutics Inc. | VYGR | Swartz Robin Chief Operating Officer |
150,000 | $0 | 222,327 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-16 4:59 pm |
N/A 2034-02-09 |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO |
390,000 | $0 | 607,987 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-16 4:58 pm |
N/A 2034-02-09 |
Voyager Therapeutics Inc. | VYGR | PFREUNDSCHUH PETER P. Chief Financial Officer |
90,000 | $0 | 239,433 (Direct) |
View |
| 2023-10-01 Option Award |
2023-10-02 4:24 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Fahey Sandell Jacquelyn Chief Legal Officer |
61,000 | $0 | 61,000 (Direct) |
View |
| 2023-09-15 Exercise |
2023-09-18 4:44 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
5,000 | $2.85 | 94,360 (Direct) |
View |
| 2023-09-15 Exercise |
2023-09-18 4:44 pm |
N/A 2032-01-13 |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
5,000 | $0 | 94,360 (Direct) |
View |
| 2023-07-10 Option Award |
2023-07-11 4:46 pm |
N/A 2033-07-10 |
Voyager Therapeutics Inc. | VYGR | Fahey Sandell Jacquelyn Chief Legal Officer |
122,000 | $0 | 122,000 (Direct) |
View |
| 2023-06-30 Exercise |
2023-07-05 4:32 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
5,000 | $2.85 | 110,360 (Direct) |
View |
| 2023-06-30 Exercise |
2023-07-05 4:32 pm |
N/A 2032-01-13 |
Voyager Therapeutics Inc. | VYGR | Carter Todd Alfred Chief Scientific Officer |
5,000 | $0 | 110,360 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 4:41 pm |
N/A 2033-06-06 |
Voyager Therapeutics Inc. | VYGR | PIERCE GLENN Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 4:40 pm |
N/A 2033-06-06 |
Voyager Therapeutics Inc. | VYGR | MACKEY CATHERINE J Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 4:40 pm |
N/A 2033-06-06 |
Voyager Therapeutics Inc. | VYGR | Vitale Nancy Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 4:39 pm |
N/A 2033-06-06 |
Voyager Therapeutics Inc. | VYGR | Onyia Jude Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 4:38 pm |
N/A 2033-06-06 |
Voyager Therapeutics Inc. | VYGR | Higgins Michael J Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 4:37 pm |
N/A 2033-06-06 |
Voyager Therapeutics Inc. | VYGR | Colon Grace Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 4:36 pm |
N/A 2033-06-06 |
Voyager Therapeutics Inc. | VYGR | GERAGHTY JAMES A Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 4:35 pm |
N/A 2033-06-06 |
Voyager Therapeutics Inc. | VYGR | SCANGOS GEORGE A Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-07 4:34 pm |
N/A 2033-06-06 |
Voyager Therapeutics Inc. | VYGR | Hyman Steven Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2023-05-09 Option Award |
2023-05-11 5:15 pm |
N/A 2033-05-09 |
Voyager Therapeutics Inc. | VYGR | SCANGOS GEORGE A Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 5:19 pm |
N/A 2033-02-23 |
Voyager Therapeutics Inc. | VYGR | Onyia Jude Director |
44,000 | $0 | 44,000 (Direct) |
View |
Ownership |
2023-02-27 5:16 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Onyia Jude Director |
0 | $0 | 2,910 (Direct) |
View |